TNMDAB

S Momsen Reincke1, Niels von Wardenburg1, Marie A Homeyer2

  • 1Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Cell
|November 2, 2023
PubMed
概括

研究人员开发了特定于NMDAR的仿制性自身抗体受体 (CAAR) T细胞以向自身免疫脑炎. 这些工程T细胞选择性地消除产生有害自身抗体的B细胞, 为NMDAR脑炎提供了有前途的新疗法.